David M. Nathan

Active 1984–2025

Also published as
David M Nathan
185
Papers
52,503
Citations
114
h-index
182
i10-index

Citations

Citations per year for David M. Nathan1977: 1 citations1984: 1 citations1985: 1 citations1986: 3 citations1987: 9 citations1988: 12 citations1989: 11 citations1990: 23 citations1991: 8 citations1992: 15 citations1993: 31 citations1994: 13 citations1995: 30 citations1996: 51 citations1997: 52 citations1998: 56 citations1999: 57 citations2000: 81 citations2001: 96 citations2002: 131 citations2003: 166 citations2004: 190 citations2005: 169 citations2006: 201 citations2007: 325 citations2008: 411 citations2009: 436 citations2010: 540 citations2011: 502 citations2012: 477 citations2013: 520 citations2014: 480 citations2015: 466 citations2016: 406 citations2017: 483 citations2018: 437 citations2019: 1,372 citations2020: 1,312 citations2021: 1,161 citations2022: 965 citations2023: 672 citations2024: 1,224 citations2025: 549 citations2026: 21 citations1978–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,456 citing papers, 27.8% of this breakdownUnited Kingdom: 1,561 citing papers, 8% of this breakdownChina: 1,328 citing papers, 6.8% of this breakdownItaly: 876 citing papers, 4.5% of this breakdownCanada: 806 citing papers, 4.1% of this breakdownGermany: 805 citing papers, 4.1% of this breakdownAustralia: 696 citing papers, 3.5% of this breakdownNetherlands: 507 citing papers, 2.6% of this breakdownSpain: 476 citing papers, 2.4% of this breakdownFrance: 459 citing papers, 2.3% of this breakdownSweden: 441 citing papers, 2.2% of this breakdownIndia: 416 citing papers, 2.1% of this breakdown
0%27.8%Other 29.6%

Fields

  • Medicine74.3%
  • Biochemistry, Genetics and Molecular Biology13.6%
  • Health Professions3%
  • Neuroscience2.5%
  • Psychology1%
  • Immunology and Microbiology0.8%
  • Other4.8%

Topics

  • Diabetes Treatment and Management6.7%
  • Diabetes Management and Research6.7%
  • Diabetes, Cardiovascular Risks, and Lipoproteins6.7%
  • Pancreatic function and diabetes3.9%
  • Metabolism, Diabetes, and Cancer3%
  • Diabetes and associated disorders2.9%
  • Other70.1%

Coauthors

All papers

Open in search
  1. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

    Authors: , , , , , , , , , , , - Nature Reviews Neurology 2018 cited by 1,521

  2. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Henry J. Pownall, J. Bruce Redmon, Judith G. Regensteiner, W. Jack Rejeski, Paul M. Ribisl, Monika M. Safford, Kerry J. Stewart, Dace Trence, Thomas A. Wadden, Rena R. Wing - The Lancet Diabetes & Endocrinology 2016 cited by 730

  3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview

    Authors: - Diabetes Care 2013 cited by 1,817

  4. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study

    Authors: - The Lancet Diabetes & Endocrinology 2015 cited by 1,022

  5. Translating the A1C Assay Into Estimated Average Glucose Values

    Authors: , , , , , , - Diabetes Care 2008 cited by 1,815

  6. Glucose Levels and Risk of Dementia

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 915

  7. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study

    Authors: , , , , , , , , , , , - Circulation 2022 cited by 168

  8. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

    Authors: , , , , , , - Diabetes Care 2008 cited by 3,837

  9. Long-Term Complications of Diabetes Mellitus

    Authors: - New England Journal of Medicine 1993 cited by 1,505

  10. Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 156

  11. Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)

    Authors: , - Diabetes Care 2021 cited by 142

  12. Association of Traumatic Brain Injury With the Risk of Developing Chronic Cardiovascular, Endocrine, Neurological, and Psychiatric Disorders

    Authors: , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2022 cited by 188

  13. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Körner, Blandine Laferrère, Harold E. Lebovitz, Wei‐Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josép Vidal, Jianping Weng, Bruce M. Wolfe - Diabetes Care 2016 cited by 971

  14. Impaired Fasting Glucose and Impaired Glucose Tolerance

    Authors: , , , , , , - Diabetes Care 2007 cited by 1,395

  15. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

    Authors: , , , , , - 2007 cited by 979

  16. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Miller, Lawrence J. Singerman, Sheila Smith-Brewer, M. NOVAK, John Quin, Saul Genuth, Mark R. Palmert, Eric J. Brown, J. McConnell, P. Pugsley, Paul Crawford, William T. Dahms, David J. Brillon, M. E. Lackaye, Szilárd Kiss, R. Chan, Anton Orlin, Mark A. Rubin, V. Reppucci, T. Lee, M. Heinemann, Shu-Lin Chang, Brian Levy, Lois Jovanovič, M. Richardson, B. Bosco, A. Dwoskin, R. Hanna, S. Barron, R. Keith Campbell, Arti Bhan, Davida Kruger, J. K. Jones, Paul Edwards, Arti Bhan, Jason Carey, Elizabeth M. Angus, Abraham Thomas, A. Galprin, Michael D. McLellan, Fred W. Whitehouse, Richard M. Bergenstal, Matthew Johnson, K. Gunyou, L. Thomas, J. Laechelt, Priscilla Hollander, M. Spencer, David M. Kendall, Robert Cuddihy, P. Callahan, S. List, John Parker Gott, Nathalie Rude, Beth A. Olson, M. Franz, G. Castle, Ruby Birk, J. Nelson, D. Freking, L. Gill, W. Mestrezat, Donnell D. Etzwiler, Kari Lock Morgan, Lloyd Paul Aiello, E. Golden, Paul G. Arrigg, V. Asuquo, Richard S. Beaser, L. Bestourous and 462 more - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 240

  17. Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Donna H. Ryan, Monika M. Safford, Brent Van Dorsten, Thomas A. Wadden, Lynne E. Wagenknecht, Jacqueline Wesche-Thobaben, Rena R. Wing - Diabetes Care 2007 cited by 1,533

  18. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2006 cited by 1,059

  19. Diabetes

    Authors: - JAMA 2015 cited by 386

  20. Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality

    Authors: , , , , , , - JAMA 2015 cited by 436

  21. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study

    Authors: , , , , , , , , , , , , - Diabetologia 2017 cited by 196

  22. Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited

    Authors: , , , , - Diabetes 2008 cited by 551

  23. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

    Authors: , , , , , , , - Diabetes 2013 cited by 271

  24. Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wendi Wildman, Constance Pepe, Ronald Goldberg, Jeanette Calles, Juliet Ojito, Sumaya Castillo-Florez, Hermes Flórez, Anna Giannella, Olga Lara, Beth Veciana, Steven M. Haffner, Helen P. Hazuda, Maria G. Montez, Kathy Hattaway, Carlos Lorenzo, Arlene Martinez, Tatiana Walker, Richard F. Hamman, Dana Dabelea, Lisa Testaverde, Denise Anderson, Alexis Bouffard, Tonya Jenkins, Dione Lenz, Leigh Perreault, David W. Price, Sheila C. Steinke, Edward S. Horton, Catherine S. Poirier, Kati Swift, Enrique Caballero, Barbara Fargnoli, Ashley Guidi, Mathew Guido, Sharon D. Jackson, Lori Lambert, Kathleen E. Lawton, Sarah Ledbury, Jessica Sansoucy, Jeanne Spellman, Steven E. Kahn, Brenda K. Montgomery, Wilfred Y. Fujimoto, Robert H. Knopp, Edward W. Lipkin, Ivy Morgan-Taggart, Anne Murillo, Lonnese Taylor, April Thomas, Elaine C. Tsai, Dace Trence, Abbas E. Kitabchi, Samuel Dagogo‐Jack, Mary E. Murphy, Laura Taylor, Jennifer Dolgoff, Debra Clark, Uzoma N. Ibebuogu, Helen Lambeth, Harriet Ricks, Lily M.K. Rutledge, Judith E. Soberman, Mark E. Molitch, Boyd E. Metzger, Mariana K. Johnson, Mimi M. Giles, Diane Larsen, Samsam C. Pen, David M. Nathan, Mary Larkin and 196 more - Diabetes Care 2019 cited by 104